3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia
11
Prostatic Neoplasms
10
Lymphoma
9
Leukemia, Monocytic, Acute
8
Leukemia, Erythroblastic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Congenital Abnormalities
7
Lymphoma, Follicular
6
Leukemia, Megakaryoblastic, Acute
6
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Leukemia, Biphenotypic, Acute
5
Recurrence
3
Sarcoma, Myeloid
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Waldenstrom Macroglobulinemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Myeloid Malignancies
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, T-Cell
1
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Mitoxantrone
×
Clear all
No trials found.